From application‐first to science‐first: A two‐phase validation framework for complex in vitro NAMs
Clinical Pharmacology & Therapeutics · 2026
DOI: 10.1002/cpt.70428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Yiguang Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health and Engineering, Johns Hopkins University, Bloomberg School of Public Health and Whiting School of Engineering, Ba…. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Validation of new approach methodologies increasingly requires developers to define a context of use (CoU) before establishing scientific credibility, constraining complex in vitro models. This CoU first strategy can impose a structural limitation on validation. We propose a two‐phase framework that separates scientific validation from context‐specific qualification, bridged by a shared data repository. Under this structure, the model's scientific capabilities and limitations inform the range of potential applications, rather than being constricted to the first CoU selected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Environmental Health and Engineering, Johns Hopkins University, Bloomberg School of Public Health and Whiting School of Engineering, Baltimore, Maryland, USA.
ORCID-Profile: Yiguang Zhu, Paul A Locke
Zitieren
APA
Zhu, Y., & Locke, P. A. (2026). From application‐first to science‐first: A two‐phase validation framework for complex in vitro NAMs. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70428
Vancouver
Zhu Y, Locke PA. From application‐first to science‐first: A two‐phase validation framework for complex in vitro NAMs. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70428
BibTeX
@article{Zhu2026,
author = {Zhu, Yiguang and Locke, Paul A},
title = {From application‐first to science‐first: A two‐phase validation framework for complex in vitro NAMs},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
doi = {10.1002/cpt.70428}
}
EUVIMED